stomach

REFERENCES

Marteau P, Guyonnet D, Lafaye de Micheaux P, Gelu S. A randomized, double-blind, controlled study and pooled analysis of two identical trials of fermented milk containing probiotic Bifi dobacterium lactis CNCM I-2494 in healthy women reporting minor digestive symptoms. Neurogastroenterol Motil. 2013 Apr;25(4):331-e252.

Masco et al, Polyphasic taxonomic analysis of Bifidobacterium animalis and Bifidobacterium lactis reveals relatedness at the subspecies level: reclassification of Bifidobacterium animalis as Bifidobacterium animalis subsp. animalis subsp. nov. and Bifidobacterium lactis as Bifidobacterium animalis subsp. lactis subsp. nov.; International Journal of Systematic and Evolutionary Microbiology; 2004, 54, 1137–1143)

Berrada N, lemeland JF, laroche g, Thouvenot P, Piaia M. Bifidobacterium from fermented milks: Survival during gastric transit. Journal of Dairy Science, 1991; 74:409-413

Pochart P, Marteau P, Bouhnik Y, goderet I, Bourlioux P, Rambaud JC. Survival of Bifidobacteria ingested via fermented milk during their passage through the human small intestine: an in vivo study using intestinal perfusion. American Journal of Clinical Nutrition, 1992; 55:78-80

Pochart P, Marteau P, Bisetti N, goderet I, Bourlioux P, Rambaud JC. Isolement des bifidobactéries dans les selles après ingestion prolongée de lait au bifidus (lB). Médecine et Maladies Infectieuses 1990; 20: 75-78 - Publication in French

Duez H, Pelletier C, Cools S, Aissi E, Cayuela C, gavini F, Bouquelet S, Neut C and Mengaud J. A colony-immunoblotting method for quatitative detection of a Bifidobacterium animalis probiotic strain in human faeces. Journal of Applied Microbiology, 2000; 88:1019-27

Collado M.C., Y. Moreno, J.M. Cobo, J.A. Mateos, M. Hernandez. Molecular detection of Bifidobacterium animalis DN-173 010 in human feces during fermented milk administration. Food Research International, 2006; 39: 530-535

He T, M g Priebe, Y Zhong, C Huang, HJM Harmsen, gC Raangs, JM Antoine, gW Welling and RJ Vonk. Effect of yogurt and bifidobacteria supplementation on the colonic microbiota in lactose-intolerant subjects. Journal of Applied Microbiology, 2007; 104(2):595-604.

Rochet V, l Rigottier-gois, A ledaire, C Andrieux, M Sutren, S Rabot, A Mogenet, J-l Bresson, S Cools, C Picard, N goupil-Feuillerat and J Doré. Survival of Bifidobacterium animalis DN-173 010 in the faecal microbiota after administration in lyophilised form or in fermented product - a randomised study in healthy adults. Journal of Molecular Microbiology and Biotechnology, 2008;14: 128-136.

Bouvier M, Méance S, Bouley C, Berta Jl and grimaud JC. Effect of consumption of a milk fermented by the probiotic strain Bifidobacterium animalis DN-173 010 on colonic transit time in healthy humans. Bioscience Microflora. 2001; 20 (2): 43-48

Méance S, Cayuela C, Turchet P, Raimondi A, lucas C and Antoine JM. A fermented milk with a Bifidobacterium probiotic strain DN-173 010 shortened oro-fecal gut transit time in elderly. Microbial Ecology in Health and Disease. 2001; 13: 217-222

Marteau P, Cuillerier E, Méance S, gerhardt MF, Myara A, Bouvier M, Bouley C, Tondu F, Bommelaer g, grimaud JC. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women : a double blind, randomized, controlled study. Alimentary Pharmacology and Therapeutics, 2002; 16: 587-593

Méance S, Cayuela C, Raimondi A, Turchet P, lucas C and Antoine JM. Recent advances in the use of functional foods: effects of the commercial fermented milk with Bifidobacterium lactis strain DN-173 010 and yoghurt strains on gut transit time in the elderly. Microbial Ecology in Health and Disease 2003; 15: 15-2

Nishida S., Ishikawa Y., Iino H. Effect of Bifidobacterium lactis DN-173 010 on the Intestinal Transit Time, the Condition of Defecation and Intestinal Microflora: A randomized, Double-blind, Placebo-controlled, Cross-over Study among Healthy Japanese Women. Pharmacometrics 2008;74 (5/6) : 99-106

Yang Y., He M., Hu g., Wei J., Pages P., Yang X., Bourdu-Naturel S. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on Chinese constipated women. World Journal of gastroenterology, 2008; 14(40): 6237-6243

Guyonnet D, O. Chassany, P. Ducrotte, C. Picard, M. Mouret, C.H. Mercier and C. Matuchansky. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel symdrome adults in primary care. A multicentre, randomised, double-blind, controlled trial. Alimentary Pharmacology and Therapeutics, 2007; 26 (3): 475-486

Agrawal A., Houghton l.A., Morris J., Reilly B.,D., guyonnet D., goupil-Feuillerat N., Schlumberger A., Jakob S. & Whorwell P.J. Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173-010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Alimentary Pharmacology and Therapeutics, 2009; 29(1): 104-114

Guyonnet D., Woodcock A., Stefani B., Trevisan C. and Hall C. Fermented milk containing Bifidobacterium lactis DN-173 010 improved self-reported digestive comfort amongst a general population of adults. A randomized, open-label, controlled, pilot study. Journal of Digestive Diseases, 2009; 10: 61-70

Guyonnet D., Schlumberger A., Mhamdi l., Jakob S., Chassany O. Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study. British Journal of Nutrition, 2009 Jul 22:1-9.

Tillisch K, Labus J, Kilpatrick L, Jiang Z, Stains J, Ebrat B, Guyonnet D, Legrain-Raspaud S, Trotin B, Naliboff B, Mayer EA. Consumption of Fermented Milk Product with Probiotic Modulates Brain Activity. Gastroenterology, 2013 Mar 5. [Epub ahead of print].

2019 Danone Ltd. All Rights Reserved. * By consuming 2 pots of Activia 125g per day during 4 weeks and maintaining a balanced diet and healthy lifestyle.